Structure Therapeutics (GPCR) has a PEG ratio of -29.25, below the sector sector average of -7.59.
Get informed when a big investor buys or sells
+ Follow-29.25
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Structure Therapeutics (GPCR) currently reports a PEG ratio of -29.25. That is below the sector sector average of -7.59. Use the charts on this page to explore Structure Therapeutics's PEG ratio history and peer comparisons.
Structure Therapeutics's PEG ratio of -29.25 is lower than the its sector sector average of -7.59. That is roughly 285.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Structure Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At -29.25, GPCR can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -29.25, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -7.59. From there, open related valuation or income-statement pages for Structure Therapeutics, and consider following GPCR for alerts when major investors trade the stock.